AAAAAA

   
Results: 1-9 |
Results: 9
TOXOPLASMOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS RELATED TO THE CHANGE OF PNEUMOCYSTIS-CARINII PROPHYLAXIS
Authors: DULLEY FL MACHADO CM NOKUI Y ZAMBON E MACEDO MCMA SILVA ACM BOEHRINGER B OSTRONOFF M MASSUMOTO C CHAMONE DF
Citation: Fl. Dulley et al., TOXOPLASMOSIS IN BONE-MARROW TRANSPLANT RECIPIENTS RELATED TO THE CHANGE OF PNEUMOCYSTIS-CARINII PROPHYLAXIS, Blood, 84(10), 1994, pp. 10000334-10000334
PERIPHERAL T-CELL LYMPHOMA
Authors: BOEHRINGER B OSTRONOFF M MACEDO MCA CONCHON M MEDEIROS RS MASSUMOTO CM DULLEY F MENEZES Y VASALO J LLACCER PD POZZI D CHAMONE DF
Citation: B. Boehringer et al., PERIPHERAL T-CELL LYMPHOMA, Blood, 84(10), 1994, pp. 10000639-10000639
STANDARD CHOP WITH REDUCED DOSE OF DOXORUBICIN (MINI-CHOP) FOR ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL)
Authors: MACEDO MCMA OSTRONOFF M SILVA R BOEHRINGER B ZAMBOM E CONCHON M MEDEIROS RS DULLEY FL MASSUMOTO C DORLHIACLLACER PE POZZI DH CHAMONE DAF
Citation: Mcma. Macedo et al., STANDARD CHOP WITH REDUCED DOSE OF DOXORUBICIN (MINI-CHOP) FOR ELDERLY PATIENTS WITH INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL), Blood, 84(10), 1994, pp. 10000644-10000644
PRECOCIOUS WITHDRAWAL OF IMMUNOSUPRESSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION AS PREVENTION OF RELAPSE IN HEMATOLOGIC MALIGNANCIES
Authors: BOEHRINGER B DULLEY FL OSTRONOFF M MACEDO MCMA SILVA ACM MASSUMOTO C ZAMBON E SABOYA R LOTERIO H CHAMONE DAF
Citation: B. Boehringer et al., PRECOCIOUS WITHDRAWAL OF IMMUNOSUPRESSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION AS PREVENTION OF RELAPSE IN HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000704-10000704
BUSULFAN, CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE AS PREPARATIVE REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR SEVERE APLASTIC-ANEMIA (SAA)
Authors: MACEDO MCMA DULLEY FL OSTRONOFF M BOEHRINGER B MASSUMOTO C ZAMBON E MEDEIROS RS LOTERIO H DORLIACLLACER PE CHAMONE DF
Citation: Mcma. Macedo et al., BUSULFAN, CYCLOPHOSPHAMIDE AND METHYLPREDNISOLONE AS PREPARATIVE REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR SEVERE APLASTIC-ANEMIA (SAA), Blood, 84(10), 1994, pp. 10000713-10000713
GANCICLOVIR VS GANCICLOVIR PLUS GM-CSF AS PROPHYLAXIS FOR CMV INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: MACEDO MCMA DULLEY FL OSTRONOFF M MACHADO CM SILVA ACM MASSUMOTO C BOEHRINGER B ZAMBON E LOTERIO H DORLHIACLLACER PE CHAMONE DF
Citation: Mcma. Macedo et al., GANCICLOVIR VS GANCICLOVIR PLUS GM-CSF AS PROPHYLAXIS FOR CMV INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000713-10000713
PRIMARY PNEUMOCYSTIS-CARINII PROPHYLAXIS WITH AEROSOLIZED PENTAMIDINEAFTER BONE-MARROW TRANSPLANTATION
Authors: MACHADO CM OSTRONOFF M SILVA ACM MACEDO MCMA BOEHRINGER B ZAMBON E NUKUI Y MASSUMOTO C DORLHIACLLACER PE CHAMONE DF DULLEY FL
Citation: Cm. Machado et al., PRIMARY PNEUMOCYSTIS-CARINII PROPHYLAXIS WITH AEROSOLIZED PENTAMIDINEAFTER BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000714-10000714
BUSULFAN PLUS MELPHALAN (BU MEL) FOLLOWED BY INTERLEUKIN-2 (IL-2) IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA (AML)/
Authors: MASSUMOTO C OSTRONOFF M ZAMBON E ALMEIDA MC BOEHRINGER B CHAMONE D DULLEY F
Citation: C. Massumoto et al., BUSULFAN PLUS MELPHALAN (BU MEL) FOLLOWED BY INTERLEUKIN-2 (IL-2) IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA (AML)/, Blood, 84(10), 1994, pp. 10000714-10000714
BUSULFAN AND MELPHALAN (BUS PLUS LPAM) AS PREPARATIVE REGIMENS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCIES
Authors: OSTRONOFF M DULLEY FL BOEHRINGER B MACEDO MCMA SILVA ACM MASSUMOTO C ZAMBON E SABOYA R LOTERIO H CHAMONE DAF
Citation: M. Ostronoff et al., BUSULFAN AND MELPHALAN (BUS PLUS LPAM) AS PREPARATIVE REGIMENS FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN HEMATOLOGIC MALIGNANCIES, Blood, 84(10), 1994, pp. 10000716-10000716
Risultati: 1-9 |